Screener
Regenxbio RGNX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
FAQ
- What is Regenxbio's total equity?
- Regenxbio (RGNX) reported total equity of $71.77M in Q2 2026.
- How has Regenxbio's total equity changed year-over-year?
- Regenxbio's total equity decreased by 66.4% year-over-year, from $213.68M to $71.77M.
- What is the long-term trend for Regenxbio's total equity?
- Over 5 years (2020 to 2025), Regenxbio's total equity has grown at a -22.9% compound annual growth rate (CAGR), from $377.75M to $102.73M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Regenxbio's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude